Maspin expression in invasive breast cancer: Association with other prognostic factors

Syed K. Mohsin*, Ming Zhang, Gary M. Clark, D. Craig Allred

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

125 Scopus citations


Maspin is a unique serine protease inhibitor with a molecular weight of 42 kDa. It has been shown to inhibit tumour cell motility and invasion in cell culture, and tumour growth and metastasis in animal models. There is very limited data on the prognostic utility of maspin in human breast cancer. We performed a preliminary study to assess the associations of maspin with other established prognostic factors in invasive breast cancer (IBC). 1068 paraffin-embedded IBCs were immunohistochemically stained with a monoclonal antibody to maspin. A nuclear signal was present in 96% and a cytoplasmic signal in 35% of the cases. Nuclear staining was related to oestrogen (ER) and progesterone receptor (PR) positivity (p < 0.0001), but not to S-phase fraction (SPF) or ploidy. Cytoplasmic staining was related to ER and PR negativity (p < 0.0001), high SPF (p < 0.0001), and aneuploidy (p = 0.003). Thus, maspin nuclear staining was significantly associated with good prognostic factors, while cytoplasmic staining was associated with poor prognostic markers. These findings suggest that the presence of maspin in two different compartments of the cell may have different biological and clinical implications. Additional studies are needed to evaluate further this expression profile of maspin in breast cancer.

Original languageEnglish (US)
Pages (from-to)432-435
Number of pages4
JournalJournal of Pathology
Issue number4
StatePublished - Apr 1 2003


  • Breast cancer
  • Immunohistochemistry
  • Maspin
  • Prognostic factors

ASJC Scopus subject areas

  • Pathology and Forensic Medicine


Dive into the research topics of 'Maspin expression in invasive breast cancer: Association with other prognostic factors'. Together they form a unique fingerprint.

Cite this